NVCR

NovoCure Ltd

—

$17.83

+2.94% today

last filing 2026-03-02Pro sees filings in ~15 min

Price

hover · 4 moves explained

4 buys19 sells12 8-K

Analyst consensus

Buy

$26.00target+45.8%vs $17.83 today

$17.00 low today target$46.00 high

7 analysts · ~12-month consensus · as of Jul 9. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 3 of last 4

Earnings per share · actual vs forecast

Q2 '25+7.3%

−$0.36

exp −$0.39

Q3 '25+21.4%

−$0.33

exp −$0.42

Q4 '25+46.5%

−$0.22

exp −$0.41

Q1 '26-20.9%

−$0.62

exp −$0.51

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Sell	2026-03-03	Paravasthu Mukund	Chief Operating Officer	—Direct	408	$13.49	$5.5K
Sell	2026-03-03	Weinberg Uri	Chf Medical and Innovation Ofr	—Direct	3,272	$13.33	$43.6K
Sell	2026-03-03	Leonard Frank X	Chief Executive Officer	—Direct	7,232	$13.49	$97.6K
Tax	2026-03-03	Cordova Ashley	Former Chief Executive Officer	—Direct	7,228	$13.67	$98.8K
Tax	2026-03-03	Cordova Ashley	Former Chief Executive Officer	—Direct	2,410	$13.67	$32.9K

Sell

Paravasthu Mukund

Chief Operating Officer · 2026-03-03

$5.5K

408 @ $13.49

Sell

Weinberg Uri

Chf Medical and Innovation Ofr · 2026-03-03

$43.6K

3,272 @ $13.33

Sell

Leonard Frank X

Chief Executive Officer · 2026-03-03

$97.6K

7,232 @ $13.49

Tax

Cordova Ashley

Former Chief Executive Officer · 2026-03-03

$98.8K

7,228 @ $13.67

Tax

Cordova Ashley

Former Chief Executive Officer · 2026-03-03

$32.9K

2,410 @ $13.67

44 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →